Breathing Helium-Hyperoxia During Exercise in Patients With Chronic Obstructive Pulmonary Disease
Does Breathing Helium-Hyperoxia Increase the Tolerance of One-Legged Exercise in Ventilatory Limited Patients With Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
15
1 country
1
Brief Summary
Regular exercise can help patients with the lung disease, chronic obstructive pulmonary disease (COPD). But COPD patients have a hard time with training because of their breathing. To improve their program they can train with one leg at a time. Another way is to make their exercise easier by breathing helium. Putting two methods, one-legged and helium, together may improve their program even more. This project is planned to assess whether breathing helium improves their one-legged exercise endurance. If it does, then there may be a reason for combining one-legged exercise with breathing helium as part of their respiratory rehabilitation program. The aim of this study is to determine whether breathing helium-hyperoxia enables a further increase in the constant power endurance time during one-legged exercise in ventilatory limited subjects with COPD. The null hypothesis is that patients will have sufficient peripheral muscle limitation that ventilatory unloading using helium-hyperoxia will be of no additional benefit to exercise tolerance. The investigators hypothesize that patients with COPD are so ventilatory limited relative to their peripheral muscles that helium-hyperoxia will improve their exercise endurance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 6, 2010
CompletedFirst Posted
Study publicly available on registry
January 26, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedJuly 11, 2012
July 1, 2012
1.5 years
July 6, 2010
July 10, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
tolerable duration of symptom-limited high-intensity exercise
1 week
Secondary Outcomes (4)
heart rate
1 week
oxygen saturation
1 week
Breathlessness
1 week
leg fatigue
1 week
Interventions
40% O2, 60% He
oxygen (4 L/min) provided by nasal cannula
Eligibility Criteria
You may qualify if:
- clinical diagnosis of COPD
- Cardiopulmonary impairment
- Ventilatory limitation
You may not qualify if:
- inability to communicate in English
- cardiac rhythm or circulatory compromise
- recent myocardial infarct
- moderate-severe aortic stenosis
- uncontrolled hypertension
- sustained cardiac arrhythmias
- untreated neoplasia
- lung surgery within the previous three months
- any other predominant co-morbidities, such as chronic heart failure, or treatments that might influence the results of exercise testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West Park Healthcare Centre
Toronto, Ontario, M6M 2J5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roger S Goldstein, MD
West Park Healthcare Centre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Program in Respiratory Rehabilitation
Study Record Dates
First Submitted
July 6, 2010
First Posted
January 26, 2011
Study Start
July 1, 2010
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
July 11, 2012
Record last verified: 2012-07